7.39 -0.35 (-4.59%)
CRA
Stock Details
Last Trade:7.39 Change:-0.35 (-4.59%) Prev Close:7.74 Open: 7.63 Days Range:7.35 – 7.79 52 Week Range: 5.03 - 17.56 Volume:430963 P/E: N/AEPS:-1.49
View AllRecent Alerts 07/03/09
Recent Alert on 06/11/09 at 3:47pm
Wedbush Morgan Initiates Coverage on Celera (CRA) with a Hold
Wedbush Morgan Initiates Coverage on Celera (CRA) with a Hold
Wedbush Morgan initiates coverage on Celera (NYSE: CRA) with a Hold. Price target $9. Wedbush analyst says, "Celera is an emerging provider of “personalized” diagnostic products and services, with an emphasis in cardiovascular disease risk... Read More
Recent Alert on 04/21/09 at 10:55am
Celera (CRA) Presents Data Describing an Immunodiagnostic Assay to Detect Lung Cancer from Blood Serum
Celera (CRA) Presents Data Describing an Immunodiagnostic Assay to Detect Lung Cancer from Blood Serum
Recent Alert on 04/21/09 at 10:55am
Celera (CRA) Presents Data Describing an Immunodiagnostic Assay to Detect Lung Cancer from Blood Serum
Celera (CRA) Presents Data Describing an Immunodiagnostic Assay to Detect Lung Cancer from Blood Serum
Recent Alert on 04/06/09 at 4:36pm
Celera (CRA) Announces Resignation of CFO; Ugo DeBlasi Named as Replacement
Celera (CRA) Announces Resignation of CFO; Ugo DeBlasi Named as Replacement
View AllRecent Press Releases
Press Release on 06/29/09 at 5:00am
Celera Grants License to Bayer Schering Pharma for Cancer-Related Targets
Celera Grants License to Bayer Schering Pharma for Cancer-Related Targets
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 06/02/09 at 8:43am
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
Blog Posts on 03/23/09 at 12:10pm
Analyst upgrades, downgrades and initiations: GLW, A, BHP, MJN, AET ...
Analyst upgrades, downgrades and initiations: GLW, A, BHP, MJN, AET ...
Blog Posts on 03/15/09 at 12:40pm
The week in preview: Interest rates, manufacturing, earnings gainers
The week in preview: Interest rates, manufacturing, earnings gainers